Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-725P (RNA, U6 small nuclear 725, pseudogene) is a human genomic locus that is a pseudogene of the U6 small nuclear RNA family. U6 snRNA is an integral part of the spliceosome, essential for pre-mRNA splicing, but pseudogenes like RNU6-725P typically arise from gene duplication or retrotransposition and acquire mutations that prevent transcription or correct processing[4][6][7][8]. Unlike expressed snRNAs, RNU6-725P is likely non-functional and does not contribute to splicing or any known RNA-mediated processes[4][7]. Pseudogenes often serve as markers for evolutionary history or rare regulatory roles, but for RNU6-725P, no functional activity or disease association is documented[6][7]. This locus is chiefly referenced in genomic studies, not clinical or pharmacological contexts[2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 725, pseudogene (RNU6-725P).